Peptides DB
Research-centric peptide and protocol reference hub
Study 29 of 29LL-37 literatureCurrent eye research · Observational2005

Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity.

LL-37 is expressed in ocular surface epithelia and shows significant antibacterial and antiviral activity in vitro, but further research is needed to confirm its clinical relevance.

Read at Current eye researchAdd to compare

Where it sits

this study against the rest of the ll-37 corpus
5
Preclinical
15
Observational · this one
0
Open-label
5
Randomised
4
Reviews

Summary and findings

This study measured the expression of LL-37 in human conjunctival and corneal epithelia and assessed its antibacterial and antiviral activity. LL-37 was expressed by these epithelial cells, and its antibacterial activity was evaluated against various pathogens. The study found LL-37 to have significant antimicrobial properties in vitro.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
EC50 values for three strains of Pseudomonas aeruginosa were 2.8 +/- 1.3, 1.9 +/- 0.3, and 3.6 +/- 2.1 microg/ml.2005

Abstract

The authors’ words, as Current eye research supplied them

<h4>Purpose</h4>This study determined whether LL-37 (cathelicidin) is expressed by conjunctival and corneal epithelia as part of ocular host defense. The antimicrobial activity of LL-37 was also assessed in vitro against Pseudomonas aeruginosa (PA), Staphylococcus aureus (SA), Staphylococcus epidermidis (SE), herpes simplex virus type 1 (HSV-1), and adenovirus (Ad).<h4>Methods</h4>Expression of LL-37/hCAP 18 mRNA and LL-37 protein was determined by reverse transcription-polymerase chain reaction (RT-PCR) and immunoblotting, respectively, in scraped human corneal epithelium and primary cultured human corneal and conjunctival epithelial cells. The EC50 values for three strains of PA and one each of SA and SE were determined for LL-37. LL-37 antiviral inhibition of HSV-1 and adenovirus was assessed by direct inactivation assays. Toxicity of LL-37 to A549 cells was evaluated by a MTT assay.<h4>Results</h4>LL-37/hCAP18 mRNA and LL-37 peptide were expressed by human corneal and conjunctival epithelial cells. Antibacterial activity for LL-37 was demonstrated (EC50 values for the three PA strains were 2.8 +/- 1.3, 1.9 +/- 0.3, and 3.6 +/- 2.1; for SA: 1.6 +/- 1.5; for SE: 1.3 +/- 1.9 microg/ml). LL-37 produced a significant reduction (p < 0.001 ANOVA) in HSV-1 and Ad19 viral titers with distinctly different time-kill curves (p < 0.001). LL-37 (up to 111 microM) produced no toxicity in A549 cells.<h4>Conclusions</h4>Corneal and conjunctival epithelia express LL-37 as part of mucosal innate immunity to protect against bacterial and viral ocular infections.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the LL-37 corpus

CPhenotypic resistance to life-saving antimicrobials in Gram-positive bacteria isolated from wild birds in Northern Italy: a One Health surveillance perspective.One health (Amsterdam, Netherlands) · 2026 · n=205 · 40.1% of isolates were Gram-positive, n=469.AnimalAAzithromycin for Preschoolers with Wheezing in the Emergency Department.The New England journal of medicine · 2026 · ADYC scores did not differ significantly between the azithromycin and placebo groups in the positive cohort (P = 0.70).HumanACarbocisteine or Hypertonic Saline for Acute Respiratory Failure.The New England journal of medicine · 2026 · Median duration of mechanical ventilation was 186.1 hours with carbocisteine and 172.7 hours with no carbocisteine, adjusted hazard ratio 0.96, P=0.34.HumanCRAD51 stabilizes neutrophil extracellular traps to compartmentalize inflammation.Science (New York, N.Y.) · 2026 · Not reported in abstract.AnimalD<em>In Vivo</em> Efficacy of LL-37 and Its Derivative Peptides Against Methicillin-Resistant <em>Staphylococcus aureus</em> in Animal Models: A Systematic Review and Meta-Analysisbiorxiv-preprint · 2026 · -7.86 standardized mean difference in bacterial eradication vs controls, 95% CI: -9.40 to -6.33, P < 0.001, n=44.reviewAHigh-dose inhaled nitric oxide for severe pneumonia caused by multidrug-resistant bacteria: a randomized controlled trial protocol.Annals of medicine · 2026 · Not reported in abstract.Human